Cynata Therapeutics Limited Stock Market Value
| CYYNF Stock | USD 0.19 0.00 0.00% |
| Symbol | Cynata |
Cynata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cynata Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cynata Therapeutics.
| 06/20/2023 |
| 12/11/2024 |
If you would invest 0.00 in Cynata Therapeutics on June 20, 2023 and sell it all today you would earn a total of 0.00 from holding Cynata Therapeutics Limited or generate 0.0% return on investment in Cynata Therapeutics over 540 days. Cynata Therapeutics is related to or competes with Forte Biosciences, Cellectar Biosciences, Virax Biolabs, Revelation Biosciences, NRX Pharmaceuticals, Biomx, and Lexaria Bioscience. Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem ... More
Cynata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cynata Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cynata Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.
Cynata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cynata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cynata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Cynata Therapeutics historical prices to predict the future Cynata Therapeutics' volatility.Cynata Therapeutics Backtested Returns
We have found three technical indicators for Cynata Therapeutics Limited, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cynata Therapeutics are completely uncorrelated.
Auto-correlation | -0.73 |
Almost perfect reverse predictability
Cynata Therapeutics Limited has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Cynata Therapeutics time series from 20th of June 2023 to 16th of March 2024 and 16th of March 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cynata Therapeutics price movement. The serial correlation of -0.73 indicates that around 73.0% of current Cynata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.73 | |
| Spearman Rank Test | -0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cynata Therapeutics lagged returns against current returns
Autocorrelation, which is Cynata Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cynata Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Cynata Therapeutics returns to help us make a trade decision. For example, suppose you find that Cynata Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cynata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cynata Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cynata Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cynata Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Cynata Therapeutics Lagged Returns
When evaluating Cynata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cynata Therapeutics pink sheet have on its future price. Cynata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cynata Therapeutics autocorrelation shows the relationship between Cynata Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Cynata Therapeutics Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Cynata Pink Sheet
Cynata Therapeutics financial ratios help investors to determine whether Cynata Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cynata with respect to the benefits of owning Cynata Therapeutics security.